The Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Backs Ultrasound Guidance for Trigger Point Care
ACR urges Medicare to cover ultrasound guidance for highârisk trigger point injections to improve safety and accuracy.
Read moreACR Supports Bill to Stabilize Medicare Physician Pay
ACR backs bipartisan H.R. 8163 which will stabilize Medicare physician pay by easing budget neutrality, fixing data errors, and capping annual cuts.
Read moreACR Flags Concern With White House FY 2027 Budget Request
ACR raises concerns about Trumpâs FY2027 budget, which cuts NIH by $6B, caps indirect costs, restructures institutes, and reduces ARPAâH funding.
Read more